Genetic vs. Genomic Testing
The terms genetic testing and genomic testing are often used in articles about cancer research. They sound similar, but they are not the same. Below are a...
Read MoreAbout MBC Awareness Day
In 2009, October 13 was established as Metastatic Breast Cancer Awareness Day. Breast Cancer Awareness Month had been on the national calendar since 1985. But its...
Read MoreTreating Brain Metastases
Studies suggest that between 15 and 30 percent of women and men with metastatic breast cancer will develop brain metastases. This number has been increasing as...
Read MoreOS vs. PFS: What You Need to Know
Clinical trials are set up to look at specific outcomes. In some trials, researchers set out to look at progression-free survival (PFS), a measure of how long...
Read MoreHow to Ask Your Doctor About Clinical Trials
As a woman or man living with metastatic breast cancer, you may have thought about whether a clinical trial would be a good option for your care. But if your...
Read MoreMore Men Needed in Breast Cancer Trials
Breast cancer is rare in men. About one percent of all breast cancer diagnoses are in men. However, when men are diagnosed, their cancer tends to be at a later...
Read MoreNew FDA Approval: A PI3K Inhibitor
In May, the U.S. Food and Drug Administration (FDA) approved Piqray® (alpelisib) for treating advanced breast cancer. It is approved for use in combination with...
Read MoreTrue or False?
You may be treated with only a placebo in a metastatic breast cancer clinical trial. Answer: False A patient with metastatic breast cancer will never...
Read MoreNew Guideline Includes Immunotherapy
In March, the immunotherapy Tecentriq® (atezolizumab) became the first to be included in NCCN Treatment Guidelines for metastatic breast cancer. It can be used...
Read MoreSEARCH OUR SITE
for past articles or specific information.